IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 986
NA - Nord America 777
AS - Asia 620
SA - Sud America 358
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 2.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 761
IE - Irlanda 496
SG - Singapore 451
BR - Brasile 325
SE - Svezia 285
IT - Italia 101
IN - India 51
CN - Cina 47
DE - Germania 18
AT - Austria 17
NL - Olanda 17
HK - Hong Kong 16
RU - Federazione Russa 14
EU - Europa 9
ZA - Sudafrica 9
AR - Argentina 8
FI - Finlandia 8
CZ - Repubblica Ceca 7
UA - Ucraina 7
BD - Bangladesh 5
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
PY - Paraguay 5
UZ - Uzbekistan 5
CA - Canada 4
EG - Egitto 4
MX - Messico 4
TR - Turchia 4
TW - Taiwan 4
CL - Cile 3
FR - Francia 3
GB - Regno Unito 3
JO - Giordania 3
LK - Sri Lanka 3
MA - Marocco 3
PE - Perù 3
PK - Pakistan 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GR - Grecia 2
ID - Indonesia 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
SV - El Salvador 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.774
Salva come PNG Salva come JPEG
Città #
Dublin 496
Nyköping 277
Singapore 266
Ashburn 110
Chandler 86
Princeton 86
Medford 85
Des Moines 64
Messina 49
Pune 46
Los Angeles 24
São Paulo 19
Boardman 15
Hong Kong 15
Rio de Janeiro 14
Wilmington 14
Nuremberg 11
Vienna 9
Jiaxing 8
Brno 7
Jinan 7
Guarulhos 6
Ningbo 6
Belo Horizonte 5
Norwalk 5
Porto Alegre 5
Rome 5
Campinas 4
Catania 4
Goiânia 4
Helsinki 4
Hyderabad 4
New York 4
Nova Iguaçu 4
Recife 4
San Francisco 4
Taizhou 4
Tashkent 4
Amman 3
Augusta 3
Baghdad 3
Bogotá 3
Brooklyn 3
Cairo 3
Catanduva 3
Caxias do Sul 3
Curitiba 3
Dhaka 3
Johannesburg 3
Kaduwela 3
Lima 3
Manaus 3
Munich 3
Nanjing 3
São Bernardo do Campo 3
São Gonçalo 3
Varjota 3
Americana 2
Araras 2
Baku 2
Bandar Seri Begawan 2
Bari 2
Belford Roxo 2
Betim 2
Cabo Frio 2
Cambé 2
Campina Grande 2
Cape Town 2
Carapicuíba 2
Casablanca 2
Cuiabá 2
Guaratuba 2
High Springs 2
Ibiporã 2
Indaiatuba 2
Ipatinga 2
Istanbul 2
Jacareí 2
Jakarta 2
Joinville 2
Manchester 2
Maricá 2
Mineiros 2
Montes Claros 2
Nanchang 2
Niterói 2
Novo Hamburgo 2
Pace del Mela 2
Petrópolis 2
Piracicaba 2
Quito 2
Redmond 2
Ribeirão das Neves 2
Rio Grande 2
Rio Verde 2
Salto 2
Salvador 2
San Salvador 2
Santo André 2
Sapucaia do Sul 2
Totale 1.927
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 164
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 48
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 48
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 48
The ubiquitin-proteasome system in Alzheimer‘s disease 47
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 47
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 44
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 44
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 43
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 43
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 42
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 40
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 40
Autophagic/lysosomal dysfunction in Alzheimer's disease 39
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 38
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 36
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 36
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 35
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 35
Alzheimer's disease: Abeta, tau and synaptic dysfunction 35
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 35
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 34
A dynamic relationship between intracellular and extracellular pools of Abeta 33
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 33
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 33
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 31
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 31
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 30
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 30
Intracellular amyloid-beta in Alzheimer‘s disease 30
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 30
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 30
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 29
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 29
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 28
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 28
Congo red and thioflavin-T analogs detect Abeta oligomers 28
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 28
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 28
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 28
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 28
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 27
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 27
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 27
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 26
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 26
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 26
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 26
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 26
Toxic role of K+ channel oxidation in mammalian brain 26
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 26
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 26
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 25
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 25
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 25
Neural stem cells improve memory in an inducible mouse model of neuronal loss 25
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 24
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 24
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 24
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 24
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 24
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 24
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 24
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 24
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 23
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 23
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 23
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 23
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 23
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 23
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 23
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 23
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 23
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 23
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 22
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 22
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 22
Cognitive decline typical of FTLD in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43 22
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 22
Dyrk1 inhibition improves Alzheimer's disease-like pathology 22
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 21
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 21
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 21
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 21
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 21
Validation of a 2-day water maze protocol in mice 21
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 21
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 21
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 20
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 20
Paving the Way for New Clinical Trials for Alzheimer's Disease 20
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 20
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 19
The role of mTOR signaling in Alzheimer disease 18
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 18
Necroptosis activation in Alzheimer's disease 16
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 16
The Role of miR-128 in Neurodegenerative Diseases 15
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 12
Generation of a Biotin-Tagged Dual-Display Phage 10
Totale 2.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 92 0
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.074 12 26 29 40 188 32 68 155 524 0 0 0
Totale 2.901